Will 2026 Radioimmunoassay Tech Finally Break The Sensitivity Barrier In Oncology
While many expected older diagnostic methods to fade, 2026 is proving that the "Golden Standard" of sensitivity—Radioimmunoassay (RIA)—is indispensable for the next generation of cancer detection. In 2026, we are seeing RIA utilized for the ultra-precise quantification of "Low-Abundance Biomarkers" that other methods like ELISA simply cannot catch. By identifying tumor markers such...
0 Commentarii 0 Distribuiri 6 Views 0 previzualizare